- Home
- ABEO vs DRTS Comparison
ABEO vs DRTS Comparison
Compare ABEO & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEO
- DRTS
- Stock Information
- Founded
- ABEO 1974
- DRTS 2015
- Country
- ABEO United States
- DRTS Israel
- Employees
- ABEO N/A
- DRTS N/A
- Industry
- ABEO Biotechnology: Pharmaceutical Preparations
- DRTS Medical/Dental Instruments
- Sector
- ABEO Health Care
- DRTS Health Care
- Exchange
- ABEO Nasdaq
- DRTS Nasdaq
- Market Cap
- ABEO 281.0M
- DRTS 300.2M
- IPO Year
- ABEO 1980
- DRTS N/A
- Fundamental
- Price
- ABEO $4.36
- DRTS $3.96
- Analyst Decision
- ABEO Strong Buy
- DRTS Strong Buy
- Analyst Count
- ABEO 5
- DRTS 1
- Target Price
- ABEO $18.20
- DRTS $9.00
- AVG Volume (30 Days)
- ABEO 1.5M
- DRTS 66.9K
- Earning Date
- ABEO 11-13-2025
- DRTS 11-18-2025
- Dividend Yield
- ABEO N/A
- DRTS N/A
- EPS Growth
- ABEO N/A
- DRTS N/A
- EPS
- ABEO 0.99
- DRTS N/A
- Revenue
- ABEO $400,000.00
- DRTS N/A
- Revenue This Year
- ABEO N/A
- DRTS N/A
- Revenue Next Year
- ABEO $324.71
- DRTS N/A
- P/E Ratio
- ABEO $4.41
- DRTS N/A
- Revenue Growth
- ABEO N/A
- DRTS N/A
- 52 Week Low
- ABEO $3.93
- DRTS $2.14
- 52 Week High
- ABEO $7.54
- DRTS $4.69
- Technical
- Relative Strength Index (RSI)
- ABEO 24.72
- DRTS 48.39
- Support Level
- ABEO $5.29
- DRTS $3.80
- Resistance Level
- ABEO $5.41
- DRTS $4.21
- Average True Range (ATR)
- ABEO 0.24
- DRTS 0.26
- MACD
- ABEO -0.08
- DRTS -0.03
- Stochastic Oscillator
- ABEO 3.49
- DRTS 29.87
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
About DRTS Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.